Suppr超能文献

成人偏头痛预防的心理疗法

Psychological therapies for the prevention of migraine in adults.

作者信息

Sharpe Louise, Dudeney Joanne, Williams Amanda C de C, Nicholas Michael, McPhee Ingrid, Baillie Andrew, Welgampola Miriam, McGuire Brian

机构信息

School of Psychology, University of Sydney, Sydney, Australia.

出版信息

Cochrane Database Syst Rev. 2019 Jul 2;7(7):CD012295. doi: 10.1002/14651858.CD012295.pub2.

Abstract

BACKGROUND

Migraine is a common neurological problem associated with the highest burden amongst neurological conditions in terms of years lived with disability. Medications can be used as prophylaxis or rescue medicines, but are costly and not always effective. A range of psychological interventions have been developed to manage migraine.

OBJECTIVES

The objective was to evaluate the efficacy and adverse events of psychological therapies for the prevention of migraine in adults.

SEARCH METHODS

We searched CENTRAL, MEDLINE, Embase, PsycINFO and CINAHL from their inception until July 2018, and trials registries in the UK, USA, Australia and New Zealand for randomised controlled trials of any psychological intervention for adults with migraine.

SELECTION CRITERIA

We included randomised controlled trials (RCTs) of a psychological therapy for people with chronic or episodic migraine, with or without aura. Interventions could be compared to another active treatment (psychological or medical), an attention-placebo (e.g. supportive counselling) or other placebo, routine care, or waiting-list control. We excluded studies where fewer than 15 participants completed each arm.

DATA COLLECTION AND ANALYSIS

We extracted study characteristics and outcome data at post-treatment and the longest available follow-up. We analysed intervention versus control comparisons for the primary outcome of migraine frequency. We measured migraine frequency using days with migraines or number of migraine attacks measured in the four weeks after treatment. In addition, we analysed the following secondary outcomes: responder rate (the proportion of participants with a 50% reduction in migraine frequency between the four weeks prior to and the four weeks after treatment); migraine intensity; migraine duration; migraine medication usage; mood; quality of life; migraine-related disability; and proportion of participants reporting adverse events during the treatment. We included these variables, where available, at follow-up, the timing of which varied between the studies. We used the GRADE approach to judge the quality of the evidence.

MAIN RESULTS

We found 21 RCTs including 2482 participants with migraine, and we extracted meta-analytic data from 14 of these studies. The majority of studies recruited participants through advertisements, included participants with migraine according to the International Classification of Headache Disorders (ICHD) criteria and those with and without aura. Most intervention arms were a form of behavioural or cognitive-behavioural therapy. The majority of comparator arms were no treatment, routine care or waiting list. Interventions varied from one 20-minute session to 14 hours of intervention. No study had unequivocally low risk of bias; all had at least one domain at high risk of bias, and 20 had two to five domains at high risk. Reporting of randomisation procedures and allocation concealment were at high or unclear risk of bias. We downgraded the quality of evidence for outcomes to very low, due to very serious limitations in study quality and imprecision. Reporting in trials was poor; we found no preregistrations stipulating the outcomes, or demonstrating equivalent expectations between groups. Few studies reported our outcomes of interest, most only reported outcomes post treatment; follow-up data were sparse.Post-treatment effectsWe found no evidence of an effect of psychological interventions for migraine frequency in number of migraines or days with migraine (standardised mean difference (SMD) -0.02, 95% confidence interval (CI) -0.17 to 0.13; 4 studies, 681 participants; very low-quality evidence).The responder rate (proportion of participants with migraine frequency reduction of more than 50%) was greater for those who received a psychological intervention compared to control: 101/186 participants (54%) with psychological therapy; 37/152 participants (24%) with control (risk ratio (RR) 2.21, 95% CI 1.63 to 2.98; 4 studies, 338 participants; very low-quality evidence). We found no effect of psychological therapies on migraine intensity (SMD -0.13, 95% CI -0.28 to 0.02; 4 studies, 685 participants). There were no data for migraine duration (hours of migraine per day). There was no effect on migraine medication usage (SMD -0.06, 95% CI -0.35 to 0.24; 2 studies, 483 participants), mood (mean difference (MD) 0.08, 95% CI -0.33 to 0.49; 4 studies, 432 participants), quality of life (SMD -0.02, 95% CI -0.30 to 0.26; 4 studies, 565 participants), or migraine-related disability (SMD -0.67, 95% CI -1.34 to 0.00; 6 studies, 952 participants). The proportion of participants reporting adverse events did not differ between those receiving psychological treatment (9/107; 8%) and control (30/101; 30%) (RR 0.16, 95% CI 0.00 to 7.85; 2 studies, 208 participants). Only two studies reported adverse events and so we were unable to draw any conclusions.We rated evidence from all studies as very low quality.Follow-upOnly four studies reported any follow-up data. Follow-ups ranged from four months following intervention to 11 months following intervention. There was no evidence of an effect on any outcomes at follow-up (very low-quality evidence).

AUTHORS' CONCLUSIONS: This review identified 21 studies of psychological interventions for the management of migraine. We did not find evidence that psychological interventions affected migraine frequency, a result based on four studies of primarily brief treatments. Those who received psychological interventions were twice as likely to be classified as responders in the short term, but this was based on very low-quality evidence and there was no evidence of an effect of psychological intervention compared to control at follow-up. There was no evidence of an effect of psychological interventions on medication usage, mood, migraine-related disability or quality of life. There was no evidence of an effect of psychological interventions on migraine frequency in the short-term or long-term. In terms of adverse events, we were unable to draw conclusions as there was insufficient evidence. High and unclear risk of bias in study design and reporting, small numbers of participants, performance and detection bias meant that we rated all evidence as very low quality. Therefore, we conclude that there is an absence of high-quality evidence to determine whether psychological interventions are effective in managing migraine in adults and we are uncertain whether there is any difference between psychological therapies and controls.

摘要

背景

偏头痛是一种常见的神经系统问题,就残疾生存年数而言,它在神经系统疾病中负担最为沉重。药物可作为预防性或急救药物使用,但成本高昂且并非总是有效。已开发出一系列心理干预措施来管理偏头痛。

目的

目的是评估心理治疗对预防成人偏头痛的疗效和不良事件。

检索方法

我们检索了CENTRAL、MEDLINE、Embase、PsycINFO和CINAHL数据库,从其创建至2018年7月,并检索了英国、美国、澳大利亚和新西兰的试验注册库,以查找针对成年偏头痛患者的任何心理干预的随机对照试验。

入选标准

我们纳入了针对慢性或发作性偏头痛患者(无论有无先兆)的心理治疗的随机对照试验(RCT)。干预措施可与另一种积极治疗(心理或药物)、注意力安慰剂(如支持性咨询)或其他安慰剂、常规护理或等待名单对照进行比较。我们排除了每个组少于15名参与者完成研究的情况。

数据收集与分析

我们提取了治疗后和最长可用随访期的研究特征和结局数据。我们分析了干预组与对照组在偏头痛频率这一主要结局上的比较。我们使用治疗后四周内偏头痛发作天数或偏头痛发作次数来衡量偏头痛频率。此外,我们分析了以下次要结局:缓解率(治疗前四周与治疗后四周偏头痛频率降低50%的参与者比例);偏头痛强度;偏头痛持续时间;偏头痛药物使用情况;情绪;生活质量;偏头痛相关残疾;以及治疗期间报告不良事件的参与者比例。在可行的情况下,我们在随访时纳入了这些变量,不同研究的随访时间各不相同。我们使用GRADE方法来判断证据质量。

主要结果

我们找到了21项RCT,共纳入2482名偏头痛患者,我们从其中14项研究中提取了荟萃分析数据。大多数研究通过广告招募参与者,纳入了符合国际头痛疾病分类(ICHD)标准的偏头痛患者,包括有先兆和无先兆的患者。大多数干预组是某种形式的行为或认知行为疗法。大多数对照臂是不治疗、常规护理或等待名单。干预措施从一次20分钟的疗程到14小时的干预不等。没有一项研究的偏倚风险明确较低;所有研究至少有一个领域存在高偏倚风险,20项研究有两到五个领域存在高偏倚风险。随机化程序和分配隐藏的报告存在高或不明确的偏倚风险。由于研究质量存在非常严重的局限性和不精确性,我们将结局的证据质量降级为极低。试验报告情况不佳;我们未发现预先注册规定结局或表明组间期望等同的情况。很少有研究报告我们感兴趣的结局,大多数仅报告了治疗后的结局;随访数据稀少。

治疗后效果

我们未发现心理干预对偏头痛发作次数或偏头痛天数的频率有影响的证据(标准化均值差(SMD)-0.02,95%置信区间(CI)-0.17至0.13;4项研究,681名参与者;极低质量证据)。

与对照组相比,接受心理干预的参与者的缓解率(偏头痛频率降低超过50%的参与者比例)更高:接受心理治疗的101/186名参与者(54%);接受对照的37/152名参与者(24%)(风险比(RR)2.21,95%CI 1.63至2.98;4项研究,338名参与者;极低质量证据)。我们未发现心理治疗对偏头痛强度有影响(SMD -0.13,95%CI -0.28至0.02;4项研究,685名参与者)。没有关于偏头痛持续时间(每天偏头痛小时数)的数据。对偏头痛药物使用情况没有影响(SMD -0.06,95%CI -0.35至0.24;2项研究,483名参与者),对情绪没有影响(均值差(MD)0.08,95%CI -0.33至0.49;4项研究,432名参与者),对生活质量没有影响(SMD -0.02,95%CI -0.30至0.26;4项研究,565名参与者),对偏头痛相关残疾也没有影响(SMD -0.67,95%CI -1.34至0.00;6项研究,952名参与者)。报告不良事件的参与者比例在接受心理治疗的患者(9/107;8%)和对照组(30/101;30%)之间没有差异(RR 0.16,95%CI 0.00至7.85;2项研究,208名参与者)。只有两项研究报告了不良事件,因此我们无法得出任何结论。

我们将所有研究的证据评为极低质量。

随访

只有四项研究报告了任何随访数据。随访时间从干预后四个月到干预后11个月不等。没有证据表明随访时对任何结局有影响(极低质量证据)。

作者结论

本综述确定了21项关于心理干预管理偏头痛的研究。我们未发现心理干预影响偏头痛频率的证据,这一结果基于四项主要为简短治疗的研究。接受心理干预的人在短期内被归类为缓解者的可能性是对照组的两倍,但这基于极低质量的证据,且随访时没有证据表明心理干预与对照组相比有效果。没有证据表明心理干预对药物使用、情绪、偏头痛相关残疾或生活质量有影响。没有证据表明心理干预在短期或长期对偏头痛频率有影响。在不良事件方面,由于证据不足,我们无法得出结论。研究设计和报告中存在高且不明确的偏倚风险、参与者数量少、实施和检测偏倚意味着我们将所有证据评为极低质量。因此,我们得出结论,缺乏高质量证据来确定心理干预对管理成人偏头痛是否有效,并且我们不确定心理治疗与对照组之间是否存在差异。

相似文献

1
Psychological therapies for the prevention of migraine in adults.成人偏头痛预防的心理疗法
Cochrane Database Syst Rev. 2019 Jul 2;7(7):CD012295. doi: 10.1002/14651858.CD012295.pub2.
5
Acupuncture for the prevention of episodic migraine.针刺预防发作性偏头痛
Cochrane Database Syst Rev. 2016 Jun 28;2016(6):CD001218. doi: 10.1002/14651858.CD001218.pub3.
6
Botulinum toxins for the prevention of migraine in adults.用于预防成人偏头痛的肉毒杆菌毒素。
Cochrane Database Syst Rev. 2018 Jun 25;6(6):CD011616. doi: 10.1002/14651858.CD011616.pub2.
10
Psychological therapies for women who experience intimate partner violence.针对遭受亲密伴侣暴力的女性的心理疗法。
Cochrane Database Syst Rev. 2020 Jul 1;7(7):CD013017. doi: 10.1002/14651858.CD013017.pub2.

引用本文的文献

7
Neurological update: neuro-otology 2023.神经科最新动态:神经耳科学 2023 年版。
J Neurol. 2023 Dec;270(12):6170-6192. doi: 10.1007/s00415-023-11922-9. Epub 2023 Aug 17.
8
Psychological Approaches for Migraine Management.偏头痛管理的心理方法。
Anesthesiol Clin. 2023 Jun;41(2):341-355. doi: 10.1016/j.anclin.2023.02.002. Epub 2023 Mar 15.

本文引用的文献

7
Psychological interventions for migraine: a systematic review.偏头痛的心理干预:一项系统评价。
J Neurol. 2016 Dec;263(12):2369-2377. doi: 10.1007/s00415-016-8126-z. Epub 2016 May 9.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验